Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
Clinical trial NCT04119050 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04119050
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2025-02-02
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.